ctDNA as a predictive biomarker in advanced breast cancer: Lessons from the MONALEESA studies
Ann Oncol
.
2023 Nov;34(11):955-959.
doi: 10.1016/j.annonc.2023.09.3111.
Authors
E Agostinetto
1
,
M Ignatiadis
1
Affiliation
1
Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.
PMID:
37996168
DOI:
10.1016/j.annonc.2023.09.3111
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Biomarkers, Tumor / genetics
Breast Neoplasms* / genetics
Female
Humans
Letrozole
Substances
Letrozole
Biomarkers
Biomarkers, Tumor